Daniel Tasse - 03 Jun 2022 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
03 Jun 2022
Transactions value $
$0
Form type
4
Filing time
07 Jun 2022, 16:23:27 UTC
Previous filing
24 Nov 2021
Next filing
14 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Award $0 +3.01K $0.00 3.01K 03 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Option (Right to Buy) Award $0 +15.3K $0.00 15.3K 03 Jun 2022 Common Stock 15.3K $22.84 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer.
F2 The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer.